Electra Therapeutics, Inc. (ETRA) Stock Research
Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and is based in South San Francisco, California.
Latest price: 7.35 · Sector: Healthcare
Recent Insider Transactions
| Insider | Type | Date | Value |
|---|---|---|---|
| GORDON CARL L | buy | 2026-11-04 | 141400 |
| GORDON CARL L | buy | 2026-11-05 | 225813.21 |
| GORDON CARL L | buy | 2026-11-04 | 35350 |
| GORDON CARL L | buy | 2026-11-03 | 190613.92 |
| GORDON CARL L | buy | 2026-11-03 | 766752 |
| GORDON CARL L | buy | 2026-11-03 | 192272 |
| GORDON CARL L | buy | 2026-11-03 | 776968 |
| GORDON CARL L | buy | 2026-11-04 | 72097.26 |
| GORDON CARL L | buy | 2026-11-04 | 288638 |
| GORDON CARL L | buy | 2026-11-05 | 915212 |